| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |